Close Menu
  • News
  • Stocks
  • Bonds
  • Commodities
  • Collectables
    • Art
    • Classic Cars
    • Whiskey
    • Wine
  • Trading
  • Alternative Investment
  • Markets
  • More
    • Economy
    • Money
    • Business
    • Personal Finance
    • Investing
    • Financial Planning
    • ETFs
    • Equities
    • Funds

Subscribe to Updates

Get the latest markets and assets news and updates directly to your inbox.

Trending Now

GHC Capital Markets hires Oberon’s Marcus Holden-Craufurd as head of investment management

November 5, 2025

How to Invest in Palladium Stocks, ETFs and More

November 5, 2025

Duane Michals Photographs Jacob Elordi for Bottega Veneta

November 5, 2025
Facebook X (Twitter) Instagram
Facebook X (Twitter) Instagram
The Asset ObserverThe Asset Observer
Newsletter
LIVE MARKET DATA
  • News
  • Stocks
  • Bonds
  • Commodities
  • Collectables
    • Art
    • Classic Cars
    • Whiskey
    • Wine
  • Trading
  • Alternative Investment
  • Markets
  • More
    • Economy
    • Money
    • Business
    • Personal Finance
    • Investing
    • Financial Planning
    • ETFs
    • Equities
    • Funds
The Asset ObserverThe Asset Observer
Home»Stocks
Stocks

Masimo plans to split off consumer tech division By Investing.com

News RoomBy News RoomMarch 25, 2024
Share
Facebook Twitter LinkedIn Pinterest Email

© Reuters.

IRVINE, Calif. – Masimo (NASDAQ:) Corporation (NASDAQ:MASI), known for its noninvasive monitoring technologies, is considering a strategic move to separate its consumer business from its core healthcare operations.

The decision, authorized by the company’s Board of Directors, is aimed at enhancing the focus and profitability of its healthcare products while establishing a new entity for consumer audio and health products.

The proposed separation would see Masimo’s consumer-oriented products, such as the Stork baby monitor and the Freedom smart watch and band, transition to a newly formed company. Meanwhile, Masimo would continue to concentrate on its professional healthcare and telehealth solutions.

Joe Kiani, the current Chairman and CEO of Masimo, is expected to lead both the existing and the new company once the separation is complete.

The move comes as part of Masimo’s broader strategy to optimize shareholder value and provide a clearer path for growth for both segments of its business. The company is currently working through the due diligence process and aims to finalize the separation promptly, pending regulatory approvals and the completion of definitive agreements.

Masimo has also reiterated its financial guidance for the first quarter and the full fiscal year of 2024, signaling confidence in its current business trajectory.

Masimo’s reputation in the field of medical technology is underpinned by its extensive product portfolio, which includes advanced patient monitoring systems, sensors, and connectivity solutions. The company’s innovative pulse oximetry technology, Masimo SET®, has been recognized in over 100 independent studies for its superior performance.

The planned separation is subject to various conditions, including regulatory review and the approval of filings with the Securities and Exchange Commission. As the process unfolds, Masimo is committed to ensuring minimal disruption to its operations and maintaining its focus on delivering high-quality healthcare solutions.

This announcement is based on a press release statement from Masimo Corporation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

‘It’s survival math every month’: The rent crisis that got Zohran Mamdani elected goes far beyond New York City

Upstart’s stock extends declines as the AI lender predicts slower growth

Obesity drugs may get Medicare access under deal with White House: reports

Here’s how Pinterest’s holiday quarter just became a worry for Wall Street

Cava trims sales outlook amid heavy competition. But it’s wary of diving into the discounting fray.

Stadiums, shows abroad keep Live Nation upbeat on next year after sales miss expectations

Palantir was the most expensive stock ever for a company of its size — until the selloff

Bitcoin slips below $100,000 for first time since June. Here’s where it might be headed next.

Opinion: A deeper dive into Fed rate cuts and China trade reveals these investing ideas

Recent Posts
  • GHC Capital Markets hires Oberon’s Marcus Holden-Craufurd as head of investment management
  • How to Invest in Palladium Stocks, ETFs and More
  • Duane Michals Photographs Jacob Elordi for Bottega Veneta
  • ‘It’s survival math every month’: The rent crisis that got Zohran Mamdani elected goes far beyond New York City
  • Nextech3D.ai: Disrupting the Global Events Management Industry with AI and Blockchain

Subscribe to Newsletter

Get the latest markets and assets news and updates directly to your inbox.

Editors Picks

How to Invest in Palladium Stocks, ETFs and More

November 5, 2025

Duane Michals Photographs Jacob Elordi for Bottega Veneta

November 5, 2025

‘It’s survival math every month’: The rent crisis that got Zohran Mamdani elected goes far beyond New York City

November 5, 2025

Nextech3D.ai: Disrupting the Global Events Management Industry with AI and Blockchain

November 5, 2025

Norman Rockwell’s Family Speaks Out About Homeland Security’s Misuse of His Artwork

November 5, 2025
Facebook X (Twitter) Instagram
© 2025 The Asset Observer. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.